Helsinki, Finland, 4 June 2025: Cezary Cerekwicki, a primary insider of
Nordhealth AS (the "Company"), has been granted 1,375 class A shares in the
Company in accordance with the Company's performance share program.
Please refer to the attached notification of trading for further details.
For further information, please contact:
Charles MacBain, CEO charles.macbain@nordhealth.com +44 75 3903 2200
Alexander Cram, CFO alexander.cram@nordhealth.com +32 470 69 30 20
This information is subject to disclosure requirements set out in the Market
Abuse Regulation EU 596/2014 Article 19 and the Norwegian Securities Trading Act
Section 5-12.
About Nordhealth
Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS
company on a mission to redefine digital healthcare. We build software that
empower veterinary and therapy professionals to provide the best possible care
experiences to their patients. Our products serve more than 60,000 veterinary
and therapy professionals across 13,000 clinics and hospitals located in over 30
countries.
Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the
Nordic region and a growing presence internationally, with 400 employees working
either remotely or from offices (collaboration hubs). Visit the company's
website at nordhealth.com (http://www.nordhealth.com).